#FDA #approval of a new drug for treating #HIV1.

#Lenacapavir is the first of a new class of #Capsid_Inhibitor drugs

Capsid inhibitors block assembly of the HIV-1 virus' protein shell and interferes with two essential steps of the virus’ evolution.

Lenacapavir is estimated to cost $42,250 for the 1st yr. Subsequent years: $39,000 annually. Insurance coverage of capsid inhibitors is unknown.

"FDA Approves First-in-Class Drug for HIV"
Medscape
Lucy Hicks
20221222
https://bityl.co/GNSd